<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hasan R</submitter><funding>University Grants Commission</funding><pagination>11</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6314952</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(1)</volume><pubmed_abstract>The present study was conducted to determine the prognostic significance of I655V SNP (rs1136201) is a genetic one in HER-2 oncoprotein in cases of colorectal cancer (CRC). We conducted a case-control study analysing 83 subjects (naïve primary CRC cases) who underwent CRC biopsy/colectomy and included 57 healthy control subjects. Analysis of HER-2 polymorphism was done by PCR-RFLP technique. The mean age was found to be 55.9 years; median age was 56 years and mode age was 54 years with a range of 43 (30-73). Males constitute 63 (75.9%) and females constitute 20 (24.1%) of patient population. According to gradewise distribution, 12 (14.45%) patients were of Grade I, 53 (63.85%) of Grade II, and 18 (21.68%) were of Grade III. We found out that out of 83 patients, 52 (62.65%) were of homozygo</pubmed_abstract><journal>3 Biotech</journal><pubmed_title>Frequency of I655V SNP of HER-2/&lt;i>neu&lt;/i> in colorectal cancer: a study from India.</pubmed_title><pmcid>PMC6314952</pmcid><funding_grant_id>F. No. 43-84/2014(SR) dated 23rd Sept. 2015</funding_grant_id><pubmed_authors>Hasan R</pubmed_authors><pubmed_authors>Bharti PS</pubmed_authors><pubmed_authors>Khan V</pubmed_authors><pubmed_authors>Verma AK</pubmed_authors><pubmed_authors>Dev K</pubmed_authors><pubmed_authors>Anees A</pubmed_authors><pubmed_authors>Bhatt D</pubmed_authors><pubmed_authors>Khan S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Frequency of I655V SNP of HER-2/&lt;i>neu&lt;/i> in colorectal cancer: a study from India.</name><description>The present study was conducted to determine the prognostic significance of I655V SNP (rs1136201) is a genetic one in HER-2 oncoprotein in cases of colorectal cancer (CRC). We conducted a case-control study analysing 83 subjects (naïve primary CRC cases) who underwent CRC biopsy/colectomy and included 57 healthy control subjects. Analysis of HER-2 polymorphism was done by PCR-RFLP technique. The mean age was found to be 55.9 years; median age was 56 years and mode age was 54 years with a range of 43 (30-73). Males constitute 63 (75.9%) and females constitute 20 (24.1%) of patient population. According to gradewise distribution, 12 (14.45%) patients were of Grade I, 53 (63.85%) of Grade II, and 18 (21.68%) were of Grade III. We found out that out of 83 patients, 52 (62.65%) were of homozygo</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jan</publication><modification>2025-06-01T03:42:53.292Z</modification><creation>2025-06-01T03:42:53.292Z</creation></dates><accession>S-EPMC6314952</accession><cross_references><pubmed>30622849</pubmed><doi>10.1007/s13205-018-1545-z</doi></cross_references></HashMap>